Gene expression profiles following intracoronary injection of mesenchymal stromal cells using a porcine model of chronic myocardial infarction

References

• Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23:845–56.
   PubMed Web of Science ®Google Scholar
• Chatterjee K, Rame JE. Systolic heart failure: chronic and acute syndromes. Crit Care Med. 2008;36:44–51.
   PubMedGoogle Scholar
• Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–42.
   PubMed Web of Science ®Google Scholar
• Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Concise review. Mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells. 2008;26:2201–10.
   PubMed Web of Science ®Google Scholar
• Sotiropoulou PA, Papamichail M. Immune properties of mesenchymal stem cells. Methods Mol Biol. 2007;407:225–43.
   Google Scholar
• Chen S, Liu Z, Tian N, Zhang J, Yei F, Duan B, . Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol. 2006;18:552–6.
   PubMedGoogle Scholar
• Shi RZ, Li QP. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Biochem Biophys Res Commun. 2008;376:247–50.
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Kloner RA. Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med. 2009;4:709–19.
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Torella D, Ellison G. Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to humans. Rev Esp Cardiol. 2006;59:1175–89.
   Web of Science ®Google Scholar
• Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, . A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J. 2008;29:251–9.
   Google Scholar
• Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod. 2006;74:46–57.
   PubMed Web of Science ®Google Scholar
• Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, . Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA. 2009;106:14022–7.
   PubMed Web of Science ®Google Scholar
• Ye NS, Zhang RL, Zhao YF, Feng X, Wang YM, Luo GA. Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro. Genom Proteom Bioinform. 2006;4:18–25.
   PubMedGoogle Scholar
• Xu H, Baldini A. Genetic pathways to mammalian heart development: recent progress from manipulation of the mouse genome. Semin Cell Dev Biol. 2007;18:77–83.
   PubMedGoogle Scholar
• Martonosi AN, Piluca S. The structure of the Ca+2-ATPase of sarcoplasmic reticulum. Acta Biochimica Polonica. 2003;50:337–65.
   Google Scholar
• Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol. 2006;291: 1015–26.
   PubMed Web of Science ®Google Scholar
• Black BL. Transcriptional pathways in second heart field development. Semin Cell Dev Biol. 2007;18:67–76.
   PubMedGoogle Scholar
• Jamali M, Rogerson PJ, Wilton S, Skerjanc IS. Nkx2–5 activity is essential for cardiomyogenesis. J Biol Chem. 2001;276: 42252–8.
   PubMedGoogle Scholar
• Peterkin T, Gibson A, Patient R. Redundancy and evolution of GATA factor requirements in development of the myocardium. Dev Biol. 2007;311:623–35.
   PubMed Web of Science ®Google Scholar
• Karamboulas C, Dakubo GD, Liu J, De Repentigny Y, Yutzey K, Wallace VA, . Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis. J Cell Sci. 2006;119:4315–21.
   PubMedGoogle Scholar
• Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300–5.
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915–24.
   PubMed Web of Science ®Google Scholar
• Rönnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci. 2004;61:2535–48.
   PubMed Web of Science ®Google Scholar
• Rajappa M, Sharma A. Biomarkers of cardiac injury: an update. Angiology. 2005;56:677–91.
   PubMed Web of Science ®Google Scholar
• Guide for the Care and Use of Laboratory Animals. National Academy of Sciences, Washington, 1996.
   Google Scholar
• European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. States of the Council of Europe, Strasbourg, 1986.
   Google Scholar
• Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, . Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103:697–705.
   PubMed Web of Science ®Google Scholar
• Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, . In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107:2290–3.
   PubMed Web of Science ®Google Scholar
• Reiber JH, Viddeleer AR, Koning G, Schalij MJ, Lange PE. Left ventricular regression equations from single plane cine and digital X-ray ventriculograms revisited. Int J Card Imaging. 1996;12:69–78.
   Google Scholar
• Nygard AB, Jørgensen CB, Cirera S, Fredholm M. Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol. 2007;8:67–72.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25:402–8.
   PubMed Web of Science ®Google Scholar
• Nassiri SM, Khaki Z, Soleimani M, Ahmadi SH, Jahanzad I, Rabbani S, . The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J Biomed Sci. 2007;14:745–55.
   Google Scholar
• Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, Vanderheyden M, . Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol. 2007;292:1095–2004.
   Google Scholar
• Kaminskas E, Farrell AT, Wang YC, Sridhara R, Pazdur R. FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension. Oncologist. 2005;10:176–82.
   PubMed Web of Science ®Google Scholar
• Moscoso I, Centeno A, López E, Rodriguez-Barbosa JI, Santamarina I, Filgueira P, . Differentiation ‘in vitro’ of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc. 2005;37:481–2.
   Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, . Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98–102.
   PubMed Web of Science ®Google Scholar
• Martins AA, Paiva A, Morgado JM, Gomes A, Pais ML. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc. 2009;41:943–6.
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, . Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362:675–6.
   Google Scholar
• Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, . Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010;121:293–305.
   PubMed Web of Science ®Google Scholar
• Torella D, Ellison GM, Karakikes I, Nadal-Ginard B. Resident cardiac stem cells. Cell Mol Life Sci. 2007;64:661–73.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–17.
   PubMed Web of Science ®Google Scholar
• Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J, . c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA. 2009;106:1808–13.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Sun Y, Xia L, Chen A, Wang Z. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg. 2008;86:1833–40.
   PubMed Web of Science ®Google Scholar
• Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, . Imtramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovas Surg. 2007;133:717–25.
   Google Scholar
• Boyle AJ, Whitbourn R, Schlicht S, Krum H, Kocher A, Nandurkar H, . Intra-coronary high-dose CD34+ stem cells in patient with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol. 2006;109:21–7.
   PubMed Web of Science ®Google Scholar
• Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, . Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112:1178–83.
   Google Scholar